SPRO logo

Spero Therapeutics (SPRO) Company Overview

Profile

Full Name:

Spero Therapeutics, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

November 2, 2017

Indexes:

Not included

Description:

Spero Therapeutics is a biopharmaceutical company focused on developing innovative treatments for bacterial infections. They aim to address antibiotic resistance by creating new therapies that target difficult-to-treat infections, improving patient outcomes and public health. Their research emphasizes advanced drug development and collaboration with healthcare professionals.

Key Details

Price

$0.86

Annual Revenue

$96.73 M(+99.13% YoY)

Annual EPS

$0.43(+134.96% YoY)

Beta

0.65

Events Calendar

Earnings

Next earnings date:

Mar 13, 2025

Recent quarterly earnings:

Nov 14, 2024

Recent annual earnings:

Mar 13, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Jan 30, 25 HC Wainwright & Co.
Buy
Dec 20, 24 Evercore ISI Group
In-Line
Dec 2, 24 HC Wainwright & Co.
Buy
Nov 18, 24 TD Cowen
Hold
Nov 15, 24 Cantor Fitzgerald
Overweight
Nov 4, 24 HC Wainwright & Co.
Buy
Oct 3, 24 HC Wainwright & Co.
Buy
Aug 6, 24 TD Cowen
Buy
Aug 6, 24 HC Wainwright & Co.
Buy
Aug 6, 24 Cantor Fitzgerald
Overweight

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Spero Therapeutics?
  • Does Spero Therapeutics pay dividends?
  • What sector is Spero Therapeutics in?
  • What industry is Spero Therapeutics in?
  • What country is Spero Therapeutics based in?
  • When did Spero Therapeutics go public?
  • Is Spero Therapeutics in the S&P 500?
  • Is Spero Therapeutics in the NASDAQ 100?
  • Is Spero Therapeutics in the Dow Jones?
  • When was Spero Therapeutics's last earnings report?
  • When does Spero Therapeutics report earnings?
  • Should I buy Spero Therapeutics stock now?

What is the ticker symbol for Spero Therapeutics?

The ticker symbol for Spero Therapeutics is NASDAQ:SPRO

Does Spero Therapeutics pay dividends?

No, Spero Therapeutics does not pay dividends

What sector is Spero Therapeutics in?

Spero Therapeutics is in the Healthcare sector

What industry is Spero Therapeutics in?

Spero Therapeutics is in the Biotechnology industry

What country is Spero Therapeutics based in?

Spero Therapeutics is headquartered in United States

When did Spero Therapeutics go public?

Spero Therapeutics's initial public offering (IPO) was on November 2, 2017

Is Spero Therapeutics in the S&P 500?

No, Spero Therapeutics is not included in the S&P 500 index

Is Spero Therapeutics in the NASDAQ 100?

No, Spero Therapeutics is not included in the NASDAQ 100 index

Is Spero Therapeutics in the Dow Jones?

No, Spero Therapeutics is not included in the Dow Jones index

When was Spero Therapeutics's last earnings report?

Spero Therapeutics's most recent earnings report was on Nov 14, 2024

When does Spero Therapeutics report earnings?

The next expected earnings date for Spero Therapeutics is Mar 13, 2025

Should I buy Spero Therapeutics stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions